Minnetronix Medical Sharpens Image Quality for the First FDA-Cleared Wireless Surgical Camera

Lazurite taps Minnetronix optical expertise to raise the bar in wireless navigation

Wireless Surgical Camera: Minnetronix Medical announces it was selected by Lazurite, which develops innovative medical devices to set new operating room standards for efficiency and patient safety, as its development and manufacturing partner for the new ArthroFree™ Wireless Surgical Camera System.

ArthoFree is the first and only such camera system to receive FDA 510(k) market clearance.

Minnetronix was chosen by Lazurite for its experience in designing, developing, manufacturing, and commercializing complex optical systems. The team of optics experts at Minnetronix optimized the ArthroFree’s image signal processing chain – the signal path an image takes to travel through the system, from initial capture on an image sensor to on-screen display. The Minnetronix team was able to reduce latency and increase image quality, enabling physicians to see high-quality real-time video from the wireless device.

“We found a technical solution to overcome the assumption that a wireless device can’t
perform as well as a traditional wired system,” said Minnetronix vice president and
general manager Matt Adams. “The ability to move from wired to wireless with the
same, or even enhanced, clarity sets a new standard in the industry.”

Minnetronix also applied its design-for-manufacturability expertise to the project,
identifying several enhancements to make the device more efficient to manufacture,
reducing cost and assembly time.

The ArthroFree System is designed to be a modular system that is drop-in compatible with existing patient data consoles, surgical displays, and endoscopes used in minimally
invasive operating rooms.

“From end-to-end, Minnetronix provides the expertise needed to commercialize the
device,” said Eugene Malinskiy, chief executive officer and cofounder of Lazurite. “Our
goal was to be the first wireless surgical camera to receive FDA clearance. The quality of our system and the manufacturability of its design were a result of our partnership with Minnetronix and two major factors in achieving our goal.”

Minnetronix’s work with Lazurite is the most recent example of the growth of the
company’s optics business. In March, it announced its role in bringing Oculogica’s
concussion diagnostic device to market and launched a strategic partnership with the
optics research organization INO.

SourceLazurite
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy